Table: AFC-HD Ams Life Science -2023/24 group results

AFC-HD AMS Life Science

15/10/2024 07:01

Oct 15 (Reuters)- 
          AFC-HD Ams Life Science Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Aug 31, 2024    Aug 31, 2023   Aug 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             30.19           25.58          31.10        16.40    
                 (+18.0 pct)     (+11.1 pct)    (+3.0 pct)   (+12.8 pct) 
  Operating          1.92            1.64           2.20         1.20    
                 (+17.3 pct)     (+61.2 pct)    (+14.6 pct)  (+17.3 pct) 
  Recurring          1.92            1.65           2.20         1.20    
                 (+16.3 pct)     (+23.1 pct)    (+14.3 pct)  (+13.2 pct) 
  Net
  Net                1.24            1.10           1.32       720 mln   
                 (+12.9 pct)     (+49.9 pct)    (+6.1 pct)   (+12.3 pct) 
  EPS             88.64 yen       78.51 yen      93.86 yen    47.80 yen  
  EPS Diluted     88.54 yen       78.46 yen                              
  Ann Div         30.00 yen       27.50 yen      32.00 yen               
  -Q2 Div         15.00 yen       12.50 yen      16.00 yen               
  -Q4 Div         15.00 yen       15.00 yen      16.00 yen               
  
  NOTE - AFC-HD Ams Life Science Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2927.T